1. Expression of integrin α‑6 is associated with multi drug resistance and prognosis in ovarian cancer
   Luwei Wei et al, 2019, Oncology Letters CrossRef
2. A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancer
   Mayuri Narvekar et al, 2014, European Journal of Pharmaceutics and Biopharmaceutics CrossRef
3. Elevated expression of JMJD6 is associated with oral carcinogenesis and maintains cancer stemness properties
   Chang-Ryul Lee et al, 2016, Carcinogenesis CrossRef
4. Dysregulated FOXM1 signaling in the regulation of cancer stem cells
   Gulab Sher et al, 2022, Seminars in Cancer Biology CrossRef
5. All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells
   Ming-Jer Young et al, 2015, Carcinogenesis CrossRef
6. Low-dose DNA-demethylating agent enhances the chemosensitivity of cancer cells by targeting cancer stem cells via the upregulation of microRNA-497
   Lin Liu et al, 2016, Journal of Cancer Research and Clinical Oncology CrossRef
7. Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells
   Sham S. Kakar et al, 2017, Oncotarget CrossRef
8. Nanog-mediated stem cell properties are critical for MBNL3-associated paclitaxel resistance of ovarian cancer
   Xueqin Sun et al, 2021, The Journal of Biochemistry CrossRef
9. The PAX2‐null immunophenotype defines multiple lineages with common expression signatures in benign and neoplastic oviductal epithelium
   Gang Ning et al, 2014, The Journal of Pathology CrossRef
10. A uniform 2,5-dihydroxybenzoic acid layer as a matrix for MALDI-FTICR MS-based lipidomics
    Yanbo Wei et al, 2015, The Analyst CrossRef
11. Mucin 1-mediated chemo-resistance in lung cancer cells
    S Y Ham et al, 2016, Oncogenesis CrossRef
12. Effect of ALDH1A1 Gene Knockout on Drug Resistance in Paclitaxel and Topotecan Resistant Human Ovarian Cancer Cell Lines in 2D and 3D Model
    Marta Nowacka et al, 2022, International Journal of Molecular Sciences CrossRef
13. Jumonji domain‐containing protein 6 protein and its role in cancer
    Jing Yang et al, 2020, Cell Proliferation CrossRef
14. Association of ALDH1A1-NEK-2 axis in cisplatin resistance in ovarian cancer cells
    Md. Hafiz Uddin et al, 2020, Heliyon CrossRef
15. Cytotoxic Effects of Strawberry, Korean Raspberry, and Mulberry Extracts on Human Ovarian Cancer A2780 Cells
    Dahae Lee et al, 2016, Preventive Nutrition and Food Science CrossRef
16. New tri- and di-alkylstannyl 2-(1H-indol-3-yl)ethanoates: synthesis, characterization and biological screenings
    Farzana Shaheen et al, 2020, Journal of Coordination Chemistry CrossRef
17. Combination of a thioxodihydroquinazolinone with cisplatin eliminates ovarian cancer stem cell-like cells (CSC-LCs) and shows preclinical potential
    Jing Ma et al, 2018, Oncotarget CrossRef
18. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism
    Eun Jin Seo et al, 2016, Stem Cells CrossRef
19. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy
    Chongyuan Zhang et al, 2017, Medical Science Monitor CrossRef
20. H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology
    Nan Han et al, 2020, International Journal of Molecular Sciences CrossRef